Sleep During Pregnancy: Changes, Risks, and Recommendations

Pregnancy produces measurable physiological and hormonal changes that disrupt sleep architecture, duration, and quality at every trimester. Poor sleep during pregnancy is associated with elevated risks for gestational hypertension, preterm labor, and prolonged labor according to the American College of Obstetricians and Gynecologists (ACOG). This page covers the mechanisms behind pregnancy-related sleep disruption, the clinical risk categories involved, the most common disorder presentations, and the decision boundaries that separate normal adaptation from conditions requiring formal evaluation. Understanding the full landscape of sleep health provides useful context for interpreting pregnancy-specific changes.

Definition and Scope

Sleep during pregnancy refers to the altered sleep patterns, disorders, and physiological changes that occur across the three trimesters of gestation, from conception through delivery at approximately 40 weeks. The scope includes normal hormonal adaptations, disorder exacerbations (particularly sleep apnea and restless legs syndrome), and the downstream health consequences for both the pregnant person and the fetus.

The National Sleep Foundation classifies pregnant individuals as a high-priority subgroup for sleep health monitoring. The American Academy of Sleep Medicine (AASM), in its clinical practice guidelines, identifies pregnancy as a period requiring heightened screening for sleep-disordered breathing. The regulatory context governing sleep health standards and clinical guidance in the United States draws from AASM, ACOG, and the Centers for Disease Control and Prevention (CDC), each publishing distinct evidence-based frameworks relevant to perinatal sleep care.

Scope boundaries are important. This topic covers sleep from conception to the immediate postpartum period (the first 6 weeks after delivery). Infant sleep after this window falls under a separate classification covered in Infant and Newborn Sleep.

How It Works

Trimester-by-Trimester Mechanism

Pregnancy-related sleep disruption follows a recognizable progression tied to hormonal and anatomical changes across three distinct trimesters.

First trimester (weeks 1–13): Progesterone levels rise sharply, producing sedation and daytime sleepiness. Total sleep time often increases, but sleep quality declines due to nocturia (nighttime urination), nausea, and breast tenderness. Core body temperature rises by approximately 0.5°C due to progesterone's thermogenic effect, fragmenting sleep onset.

Second trimester (weeks 14–27): Progesterone stabilizes and subjective sleep quality often improves temporarily. However, uterine expansion begins displacing the diaphragm and compressing abdominal structures, elevating the risk of snoring. According to research published in Sleep Medicine Reviews, snoring prevalence increases from roughly 14% pre-pregnancy to 28% by the third trimester.

Third trimester (weeks 28–40): This trimester produces the most severe and clinically significant sleep disruption. Fetal movement, back pain, lower limb discomfort, gastroesophageal reflux, and urinary frequency combine to fragment sleep architecture. Sleep efficiency — the ratio of time asleep to time in bed — drops measurably. The supine sleep position compresses the inferior vena cava, reducing cardiac return and creating hemodynamic risk, which is why ACOG advises left lateral positioning after 28 weeks.

Sleep Architecture Changes

Sleep stages and cycles shift predictably during pregnancy. Slow-wave sleep (N3) decreases across gestation, particularly in the third trimester. REM sleep is suppressed by elevated progesterone. Fragmentation of N2 and N3 stages is observed through polysomnographic studies, consistent with the fatigue and non-restorative sleep reported clinically.

Common Scenarios

Four disorder categories account for the majority of clinically significant sleep presentations during pregnancy:

1. Restless Legs Syndrome (RLS): Prevalence increases 2–3 times above the general population baseline during pregnancy, affecting an estimated 26% of pregnant individuals by the third trimester (National Institutes of Health, Office of Dietary Supplements). Iron and folate deficiency are identified contributing factors. Symptoms — urge to move the legs accompanied by uncomfortable sensations — worsen at rest and disrupt sleep onset.

2. Obstructive Sleep Apnea (OSA): Upper airway narrowing from weight gain and mucosal edema elevates OSA risk. AASM clinical data indicate OSA prevalence during pregnancy ranges from 10% to 26% depending on trimester and body mass index. Untreated OSA during pregnancy is associated with gestational diabetes and preeclampsia in peer-reviewed literature.

3. Insomnia: Defined by AASM as difficulty initiating or maintaining sleep at least 3 nights per week for a minimum of 3 months, insomnia presentations during pregnancy often have shorter duration but significant functional impact. Physical discomfort and anxiety about labor are the primary drivers. Cognitive behavioral therapy for insomnia (CBT-I) is the first-line recommended intervention for insomnia during pregnancy when pharmacological options carry fetal safety concerns.

4. Circadian Disruption: Circadian rhythm shifts are common in the third trimester, driven by light exposure changes, physical discomfort limiting adherence to regular schedules, and hormonal fluctuation. Delayed sleep phase patterns are frequently reported.

Decision Boundaries

Distinguishing normal pregnancy-related sleep change from a condition requiring formal clinical evaluation depends on symptom pattern, severity, and functional impact.

Normal adaptation (monitoring only):
- Increased total sleep time in the first trimester with preserved daytime function
- Mild nocturia (1–2 episodes per night) without respiratory symptoms
- Positional discomfort manageable with lateral positioning and pillow support
- Transient insomnia lasting fewer than 4 consecutive weeks without daytime impairment

Elevated risk — clinical screening indicated:
- Habitual snoring starting after week 20 with observed apneas or gasping
- Daytime sleepiness disproportionate to nighttime sleep opportunity (Epworth Sleepiness Scale score above 10)
- RLS symptoms interfering with sleep onset more than 3 nights per week
- Hypertension developing concurrently with sleep complaints

Formal evaluation required:
- Witnessed apneas during sleep
- Oxygen desaturation episodes identified by home monitoring
- Insomnia exceeding 3 months with impaired daytime function
- Sleep-related complaints co-occurring with elevated blood pressure, fetal growth restriction, or gestational diabetes diagnosis

The home sleep testing and polysomnography pathways differ in sensitivity for pregnant populations; AASM guidance notes that standard home sleep apnea tests may underestimate AHI (apnea-hypopnea index) in pregnancy due to positional constraints and altered respiratory patterns. Clinical judgment determines which diagnostic pathway applies in each case.

References

• American College of Obstetricians and Gynecologists (ACOG) — Sleep During Pregnancy
• American Academy of Sleep Medicine (AASM) — Clinical Resources and Practice Guidelines
• National Institutes of Health — Restless Legs Syndrome Fact Sheet
• Centers for Disease Control and Prevention — Maternal and Infant Health
• National Heart, Lung, and Blood Institute — Sleep Deprivation and Deficiency
• National Sleep Foundation — Sleep Health Index

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)